Jordan Abdi is a biotech entrepreneur working at the frontier of reproductive biology and drug discovery. With a background spanning clinical science and translational research, he is focused on tackling one of the most fundamental challenges in human health: age-related fertility decline.
He is part of the team behind U-Ploid Biotechnologies, a company developing first-in-class approaches to prevent aneuploidy by intervening upstream in egg biology, shifting the paradigm from selection to prevention.
Jordan is particularly interested in how emerging platform technologies can unlock entirely new categories of medicine, and how these breakthroughs move from lab to clinic to global impact.